[HTML][HTML] Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Abstract P-glycoprotein (P-gp) is a drug efflux transporter that triggers doxorubicin (DOX)
resistance. In this review, we highlight the molecular avenues regulating P-gp, such as Nrf2 …
resistance. In this review, we highlight the molecular avenues regulating P-gp, such as Nrf2 …
[HTML][HTML] Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …
DRESIS: the first comprehensive landscape of drug resistance information
X Sun, Y Zhang, H Li, Y Zhou, S Shi… - Nucleic acids …, 2023 - academic.oup.com
Widespread drug resistance has become the key issue in global healthcare. Extensive
efforts have been made to reveal not only diverse diseases experiencing drug resistance …
efforts have been made to reveal not only diverse diseases experiencing drug resistance …
[HTML][HTML] Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons
M Akman, DC Belisario, IC Salaroglio… - Journal of Experimental …, 2021 - Springer
Solid tumors often grow in a micro-environment characterized by< 2% O 2 tension. This
condition, together with the aberrant activation of specific oncogenic patwhays, increases …
condition, together with the aberrant activation of specific oncogenic patwhays, increases …
[HTML][HTML] Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies
CM Hattinger, MP Patrizio, L Fantoni, C Casotti… - Cancers, 2021 - mdpi.com
Simple Summary Despite the adoption of aggressive, multimodal treatment schedules, the
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …
[HTML][HTML] Fabrication of a hydroxyapatite-PDMS microfluidic chip for bone-related cell culture and drug screening
Bone is an important part of the human body structure and plays a vital role in human health.
A microfluidic chip that can simulate the structure and function of bone will provide a platform …
A microfluidic chip that can simulate the structure and function of bone will provide a platform …
Protein persulfidation: Rewiring the hydrogen sulfide signaling in cell stress response
The past few decades have witnessed significant progress in the discovery of hydrogen
sulfide (H 2 S) as a ubiquitous gaseous signaling molecule in mammalian physiology, akin …
sulfide (H 2 S) as a ubiquitous gaseous signaling molecule in mammalian physiology, akin …
Engineering macromolecular nanocarriers for local delivery of gaseous signaling molecules
In addition to being notorious air pollutants, nitric oxide (NO), carbon monoxide (CO), and
hydrogen sulfide (H 2 S) have also been known as endogenous gaseous signaling …
hydrogen sulfide (H 2 S) have also been known as endogenous gaseous signaling …
What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
T Alexa-Stratulat, M Pešić, AČ Gašparović… - Drug resistance …, 2019 - Elsevier
Identification of multidrug (MDR) efflux transporters that belong to the ATP-Binding Cassette
(ABC) superfamily, represented an important breakthrough for understanding cancer …
(ABC) superfamily, represented an important breakthrough for understanding cancer …
An update on emerging drugs in osteosarcoma: towards tailored therapies?
CM Hattinger, MP Patrizio, F Magagnoli… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Current treatment of conventional and non-conventional high-grade
osteosarcoma (HGOS) is based on the surgical removal of primary tumor and, when …
osteosarcoma (HGOS) is based on the surgical removal of primary tumor and, when …